Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19.

Solun, B; Shoenfeld, Y

Solun, B; Shoenfeld, Y.

Afiliación

Solun B; Department of Internal Medicine D, Hasharon Hospital, Rabin Medical Center, Petah Tikva, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Israel.
Shoenfeld Y; Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to Tel-Aviv University, Israel Laboratory of the Mosaics of Autoimmunity, Sechenov First Moscow State Medical University of the Ministry of Health of, the Russian Federation.

Med Drug Discov ; 7: 100052, 2020 Sep.

Article en En | MEDLINE | ID: mdl-32537610

Palabras clave

COVID-19; acute lung injury; acute respiratory distress syndrome; aprotinin; cytokines; kinin-kallikrein system; metalloproteinases

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Med Drug Discov Año: 2020 Tipo del documento: Article País de afiliación: Israel

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google